Literature DB >> 19826502

Vigabatrin's complicated journey--to be or not to be?

Elinor Ben-Menachem.   

Abstract

Year:  2009        PMID： 19826502      PMCID： PMC2759041          DOI： 10.1111/j.1535-7511.2009.01316.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  14 in total

Review 1.  Basic developmental rules and their implications for epilepsy in the immature brain.

Authors:  Yehezkel Ben-Ari
Journal:  Epileptic Disord       Date:  2006-06       Impact factor: 1.819

2.  Effect of elevated brain GABA concentrations on the actions of bicuculline and picrotoxin in mice.

Authors:  P J Schechter; Y Tranier
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

3.  Severe persistent visual field constriction associated with vigabatrin.

Authors:  T Eke; J F Talbot; M C Lawden
Journal:  BMJ       Date:  1997-01-18

4.  The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients.

Authors:  E Ben-Menachem; L I Persson; P J Schechter; K D Haegele; N Huebert; J Hardenberg; L Dahlgren; J P Mumford
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 5.  The potential for vigabatrin-induced intramyelinic edema in humans.

Authors:  J A Cohen; R S Fisher; M G Brigell; R G Peyster; G Sze
Journal:  Epilepsia       Date:  2000-02       Impact factor: 5.864

Review 6.  Vigabatrin: 2008 update.

Authors:  L James Willmore; Mark B Abelson; Elinor Ben-Menachem; John M Pellock; W Donald Shields
Journal:  Epilepsia       Date:  2009-02       Impact factor: 5.864

7.  Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy.

Authors:  James W Wheless; Lionel Carmant; Martina Bebin; Joan A Conry; Catherine Chiron; Roy D Elterman; Michael Frost; Juliann M Paolicchi; W Donald Shields; Elizabeth A Thiele; Mary L Zupanc; Stephen D Collins
Journal:  Epilepsia       Date:  2008-11-17       Impact factor: 5.864

8.  Visual fields at school-age in children treated with vigabatrin in infancy.

Authors:  Eija Gaily; Henna Jonsson; Marjatta Lappi
Journal:  Epilepsia       Date:  2009-02       Impact factor: 5.864

9.  Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy.

Authors:  E B Menachem; L I Persson; P J Schechter; K D Haegele; N Huebert; J Hardenberg; L Dahlgren; J P Mumford
Journal:  Epilepsy Res       Date:  1988 Mar-Apr       Impact factor: 3.045

Review 10.  Visual field defects with vigabatrin: epidemiology and therapeutic implications.

Authors:  R Kälviäinen; I Nousiainen
Journal:  CNS Drugs       Date:  2001       Impact factor: 6.497
View more
  1 in total

1.  New antiepileptic drugs: lacosamide, rufinamide, and vigabatrin.

Authors:  Laura A Strom; Susan Koh; Lauren Frey
Journal:  Curr Treat Options Neurol       Date:  2010-07       Impact factor: 3.598
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.